Type of Study:
Medication
Study Length:
6 Months
Target Age/Sex:
Female - 18 years or older
Benefits:
Participants will receive at no cost: study visits and study-specific procedures. Participants may also receive compensation for time and travel.
Staus: Enrolling
Description:
This clinical research study is an open-label, randomized, parallel group of participants using either Mirena or oral Medroxyprogesterone acetate to examine the efficacy for the treatment of non-atypical endometrial hyperplasia over a period of 6 months. This study design includes no blinding.
For more information, call 208-557-2924 or fill out the form on this page.